Inventor · disambiguated record
Hon-Chung Tsui
Also filed as: TSUI HON-CHUNG
19 granted patents·9 pending applications·185 citations·filing 2002–2018
94Inventor score
Top patents by PatentIndex Score
28 records- 0194US7049320B2NK1 antagonistsSCHERING CORP·Filed 2002·Granted May 23, 2006·54 cites·17 claims
- 0292US7902366B2NK1 antagonistsOPKO HEALTH INC·Filed 2006·Granted Mar 8, 2011·19 cites·19 claims
- 0392US7709641B2NK1 antagonistsOPKO HEALTH INC·Filed 2005·Granted May 4, 2010·20 cites·30 claims
- 0489US8026364B2NK1 antagonistsOPKO HEALTH INC·Filed 2010·Granted Sep 27, 2011·11 cites·39 claims
- 0588US8796299B2NK1 antagonistsOPKO HEALTH INC·Filed 2012·Granted Aug 5, 2014·9 cites·15 claims
- 0687US8273895B2NK1 antagonistsPALIWAL SUNIL·Filed 2010·Granted Sep 25, 2012·12 cites·3 claims
- 0786US8546404B2Compounds that are ERK inhibitorsCOOPER ALAN B·Filed 2007·Granted Oct 1, 2013·9 cites·76 claims
- 0884US8754216B2NK1 antagonistsSHAH SAPNA S·Filed 2011·Granted Jun 17, 2014·9 cites·38 claims
- 0984US7122677B2NK1 antagonistsSCHERING CORP·Filed 2002·Granted Oct 17, 2006·26 cites·23 claims
- 1079US7354922B2Bridged ring NK1 antagonistsSCHERING CORP·Filed 2005·Granted Apr 8, 2008·4 cites·30 claims
- 1178US9469629B2NK1 antagonistsOPKO HEALTH INC·Filed 2014·Granted Oct 18, 2016·2 cites·12 claims
- 1278US8552191B2Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compoundsMERGELSBERG INGRID·Filed 2008·Granted Oct 8, 2013·6 cites·11 claims
- 1373US8716483B2Compounds that are ERK inhibitorsCOOPER ALAN B·Filed 2009·Granted May 6, 2014·2 cites·12 claims
- 1469US9260428B2Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compoundsOPKO HEALTH INC·Filed 2013·Granted Feb 16, 2016·1 cites·9 claims
- 1566US8623857B2N-phenyl imidazole carboxamide inhibitors of 3-phosphoinositide-dependent protein kinase-1TSUI HON-CHUNG·Filed 2011·Granted Jan 7, 2014·1 cites·18 claims
- 1664US9688693B2NK1 antagonistsOPKO HEALTH INC·Filed 2014·Granted Jun 27, 2017·0 cites·8 claims
- 1764US2018215729A1Nk 1 antagonistsOPKO HEALTH INC·Filed 2018·Application pending·0 cites
- 1862US9969711B2NK1 antagonistsOPKO HEALTH INC·Filed 2016·Granted May 15, 2018·0 cites·6 claims
- 1961US2017283434A1Nk1 antagonistsOPKO HEALTH INC·Filed 2017·Application pending·0 cites
- 2054US10000493B2Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compoundsOPKO HEALTH INC·Filed 2016·Granted Jun 19, 2018·0 cites·1 claims
- 2148US2010068181A1Pyrrolo [3, 2-a] pyridine derivatives for inhibiting ksp kinesin activitySCHERING CORP·Filed 2007·Application pending·0 cites
- 2247US2011038876A1Heterocyclic compounds and use thereof as erk inhibitorsSUN ROBERT·Filed 2008·Application pending·0 cites
- 2344US7498438B2Fused ring NK1 antagonistsSCHERING CORP·Filed 2005·Granted Mar 3, 2009·0 cites·24 claims
- 2441US2007191604A1Novel compounds that are ERK inhibitorsCOOPER ALAN·Filed 2006·Application pending·0 cites
- 2541US2006247320A1Compounds for inhibiting KSP kinesin activitySCHERING CORP·Filed 2006·Application pending·0 cites
- 2640US2006281778A1Compounds for inhibiting KSP Kinesin activitySCHERING CORP·Filed 2006·Application pending·0 cites
- 2734US2013165450A1Novel Thiazol-Carboximide Derivatives as PDK1 InhibitorsTSUI HON-CHUNG·Filed 2011·Application pending·0 cites
- 2833US2013053382A1Inhibitors of Phosphoinositide Dependent Kinase 1 (PDK1)PALIWAL SUNIL·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →